SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Ranbaxy Laboratories
Ranbaxy Laboratories
BSE: 500359|NSE: RANBAXY|ISIN: INE015A01028|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Jan 30, 16:30
703.65
-4.35 (-0.61%)
VOLUME 87,503
LIVE
NSE
Jan 30, 16:30
702.60
-6.6 (-0.93%)
VOLUME 827,773
News on Ranbaxy Laboratories
Select Year: 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Sun-Ranbaxy's $4bn merger deal gets USFTC's conditional nod

2.23 pm | 31 Jan 2015 |  Source: CNBC-TV18

Approval subject to divestment of one antibiotic product to avoid anticompetitive impact in the US mkt...

Buy Ranbaxy Labs; target of Rs 800: Motilal Oswal

4.52 pm | 30 Jan 2015 |  Source: Moneycontrol.com

Brokerage house Motilal Oswal is bullish on Ranbaxy Laboratories and has recommended buy rating on the stock with a target price of Rs 800, in its res...

Accumulate Ranbaxy; target Rs 780: KRChoksey

4.50 pm | 30 Jan 2015 |  Source: Moneycontrol.com

KRChoksey is bullish on Ranbaxy Laboratories and has recommended accumulate rating on the stock with a target price of Rs 780 in its January 29, 2015 ...

Ranbaxy Q3 disappoints; US mkt, Diovan led to loss: Angel 

3.08 pm | 28 Jan 2015 |  Source: CNBC-TV18

Speaking to CNBC-TV18, Sarabjit Kaur Nangra of Angel Broking said on the bottomline, margins suffered due to forex loss. The drug maker reported a for...

Six in Sixty: Stocks you should keep on your radar 

3.03 pm | 28 Jan 2015 |  Source: CNBC-TV18

CNBC-TV18's Sonia Shenoy lists out stocks that you should focus on – Asian Paints, Maruti, HDFC Bank, Lupin, Tata Motors, Tata Motors DVR, Titan, Ra...

Ranbaxy posts Q3 loss of Rs 1030cr; revenue at Rs 2619cr 

2.49 pm | 28 Jan 2015 |  Source: Moneycontrol.com

Troubled pharmaceuticals firm Ranbaxy Laboratories consolidated posted a consolidated net loss of Rs 1,030 crore compared to Rs 159 crore in the same ...

Ranbaxy Labs Q3 revenue may rise 12% to Rs 3236 cr: Poll 

11.15 am | 28 Jan 2015 |  Source: CNBC-TV18

Ranbaxy Laboratories, which will soon become a part of Sun Pharma, will announce its third quarter (October-December) earnings today. Analysts expect ...

Stocks in news: Bharti, Idea, Titan, L&T, Ranbaxy, Hindalco

8.23 am | 28 Jan 2015 |  Source: CNBC-TV18

Bharti Airtel | Tata Motors | Idea Cellular | Yes Bank | GMR Infrastructure | Amara Raja Batteries | Titan Company | Sadbhav Engineering | Gammon Infr...

Teva to gain post Ranbaxy's exclusivity loss for Nexium 

10.22 pm | 27 Jan 2015 |  Source: CNBC-TV18

Ranbaxy has lost out on its last big drug opportunity in the US market. The US drug regulator has denied the company 180-day exclusivity for the gener...

Six in Sixty: Stocks you should keep on your radar 

2.59 pm | 27 Jan 2015 |  Source: CNBC-TV18

CNBC-TV18's Sonia Shenoy lists out stocks that you should focus on – Maruti, Ranbaxy, BEL, Max India, HDIL, Tata Motors, Asian paints, Cipla, HDFC b...

'Ranbaxy's Nexium generic loss may up Cipla's EPS 3-5%' 

2.19 pm | 27 Jan 2015 |  Source: CNBC-TV18

The US FDA’s decision to revoke the 180-day exclusivity cover extended to Indian firm Ranbaxy to sell a generic version of the world’s second-larg...

Ranbaxy forfeits 180 days exclusivity for stomach drugs

1.17 pm | 27 Jan 2015 |  Source: PTI

Drug major Ranbaxy today said that the US health regulator has "determined" that the Indian drug manufacturer has forfeited its 180 days exclusivity f...

Here are top 10 stocks to focus on January 27 

8.54 am | 27 Jan 2015 |  Source: CNBC-TV18

Here are top 10 stocks to focus on January 27 - HDFC, Hindustan Unilever (HUL), Larsen and Toubro (L&T), Bharat Heavy Electricals (BHEL), Ultratech Ce...

Stocks in news: TVS Motor, SBI, Ranbaxy, Hindalco, Maruti

8.34 am | 27 Jan 2015 |  Source: CNBC-TV18

Hindalco Industries | TVS Motor | SBI | Ranbaxy Labs | Maruti Suzuki | Idea Cellular | United Spirits | City Union Bank | Tata Coffee | Persistent Sys...

Sun Pharma chief expects Ranbaxy deal to be done by mid-Feb

4.54 pm | 25 Jan 2015 |  Source: PTI

Drug major Sun Pharma's top executive Dilip S Shanghvi expects the USD 4-billion Ranbaxy deal to be concluded by middle of next month while stating th...

Buy Lupin 1500 call, Ranbaxy 700 Call: VK Sharma 

11.13 am | 23 Jan 2015 |  Source: CNBC-TV18

VK Sharma of HDFC Securities recommends buying Lupin 1500 call and Ranbaxy Labs 700 Call....

Six in Sixty: Stocks you should keep on your radar 

2.49 pm | 22 Jan 2015 |  Source: CNBC-TV18

CNBC-TV18's Ekta Batra lists out stocks that you should focus on – Suzlon, Sun Pharma, Ranbaxy, HUL, ITC, Zee Entertainment, Cairn India, Tata Motor...

Patent denied on Gilead's Hepatitis C drug Sovaldi

8.49 pm | 15 Jan 2015 |  Source: CNBC-TV18

The order is a big set back for Gilead. The patent denial comes close to a decade after Gilead first filed its patent application and was close to a l...

Merck Millipore bets big on India amid regulatory concerns 

9.51 pm | 08 Jan 2015 |  Source: CNBC-TV18

Indian drug makers are finding themselves under the gun as run-ins with global drug regulators are on the rise. This is being seen as a golden opportu...

Prefer pharma space, says Dilip Bhat 

11.26 am | 31 Dec 2014 |  Source: CNBC-TV18

According to Dilip Bhat of Prabhudas Lilladher, one may bet on pharmaceutical space....

1 2 3 4 5 6
Quick Links for Ranbaxy Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.